<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39434376</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>22</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>27</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1469-4409</ISSN><JournalIssue CitedMedium="Internet"><Volume>152</Volume><PubDate><Year>2024</Year><Month>Oct</Month><Day>22</Day></PubDate></JournalIssue><Title>Epidemiology and infection</Title><ISOAbbreviation>Epidemiol Infect</ISOAbbreviation></Journal><ArticleTitle>Impact of non-pharmaceutical interventions during the COVID-19 pandemic on pathogens transmitted via food in the Netherlands.</ArticleTitle><Pagination><StartPage>e130</StartPage><MedlinePgn>e130</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e130</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1017/S0950268824000815</ELocationID><Abstract><AbstractText>The COVID-19 pandemic impacted the transmission of many pathogens. The aim was to determine the effect of non-pharmaceutical interventions on the incidence of diseases transmitted via food. Weekly incidence rates for nine foodborne pathogens were collected from national surveillance registries. Weekly pathogen incidence during lockdown weeks of 2020 and 2021 were compared with corresponding weeks in 2015-2019. The same analyses were performed to determine the effect of self-defined expected impact levels of measures (low, intermediate and high). Eight out of 9 diseases showed a significant decrease in case number in 2020, except for listeriosis, which remained unchanged. The largest decrease was observed for rotavirus gastronteritis A (-81%), norovirus gastroenteritis (-78%), hepatitis A (-75%) and shigellosis (-72). In 2021, lower case numbers were observed for 6 out of 9 diseases compared with 2015-2019, with the largest decrease for shigellosis (-5/%) and hepatitis E (-47%). No significant change was observed for listeriosis, STEC infection and rotavirus gastroenteritis. Overall, measures with increased expected impact level did not result in a larger decrease in number of cases, except for Campylobacter, and norovirus and rotavirus gastroenteritis. Disease transmitted via food significantly decreased during the COVID-19 pandemic, with a more pronounced effect during 2020 than 2021.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pijnacker</LastName><ForeName>Roan</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-6408-3074</Identifier><AffiliationInfo><Affiliation>Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mughini-Gras</LastName><ForeName>Lapo</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Risk Assessment Sciences, Utrecht University, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Verhoef</LastName><ForeName>Linda</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Office for Risk Assessment &amp; Research, Netherlands Food and Consumer Product Safety Authority (NVWA), Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van den Beld</LastName><ForeName>Maaike</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Franz</LastName><ForeName>Eelco</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Friesema</LastName><ForeName>Ingrid</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0001-9943-0518</Identifier><AffiliationInfo><Affiliation>Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Epidemiol Infect</MedlineTA><NlmUniqueID>8703737</NlmUniqueID><ISSNLinking>0950-2688</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000635" MajorTopicYN="N">transmission</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009426" MajorTopicYN="N" Type="Geographic">Netherlands</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005517" MajorTopicYN="Y">Foodborne Diseases</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005759" MajorTopicYN="N">Gastroenteritis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">foodborne infections</Keyword><Keyword MajorTopicYN="N">non-pharmaceutical interventions</Keyword><Keyword MajorTopicYN="N">public health</Keyword><Keyword MajorTopicYN="N">surveillance</Keyword></KeywordList><CoiStatement>The authors declare none.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>22</Day><Hour>6</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>22</Day><Hour>6</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>22</Day><Hour>1</Hour><Minute>12</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>22</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39434376</ArticleId><ArticleId IdType="pmc">PMC11502420</ArticleId><ArticleId IdType="doi">10.1017/S0950268824000815</ArticleId><ArticleId IdType="pii">S0950268824000815</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kuo SC, et al. (2020) Collateral benefit of COVID-19 control measures on influenza activity, Taiwan. Emerging Infectious Diseases 26, 1928–1930.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7392415</ArticleId><ArticleId IdType="pubmed">32339091</ArticleId></ArticleIdList></Reference><Reference><Citation>Olsen SJ, et al. (2020) Decreased influenza activity during the COVID-19 pandemic-United States, Australia, Chile, and South Africa, 2020. American Journal of Transplantation 20, 3681–3685.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7753605</ArticleId><ArticleId IdType="pubmed">33264506</ArticleId></ArticleIdList></Reference><Reference><Citation>Soo RJJ, et al. (2020) Decreased influenza incidence under COVID-19 control measures, Singapore. Emerging Infectious Diseases 26, 1933–1935.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7392467</ArticleId><ArticleId IdType="pubmed">32339092</ArticleId></ArticleIdList></Reference><Reference><Citation>Sullivan SG, et al. (2020) Where has all the influenza gone? The impact of COVID-19 on the circulation of influenza and other respiratory viruses, Australia, March to September. Euro Surveillance 2020, 25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7693168</ArticleId><ArticleId IdType="pubmed">33243355</ArticleId></ArticleIdList></Reference><Reference><Citation>Ullrich A, et al. (2021) Impact of the COVID-19 pandemic and associated non-pharmaceutical interventions on other notifiable infectious diseases in Germany: An analysis of national surveillance data during week 1-2016 - week 32-2020. The Lancet Regional Health Europe 6, 100103.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8454829</ArticleId><ArticleId IdType="pubmed">34557831</ArticleId></ArticleIdList></Reference><Reference><Citation>Huh K, et al. (2021) Impact of nonpharmaceutical interventions on the incidence of respiratory infections during the coronavirus disease 2019 (COVID-19) outbreak in Korea: A nationwide surveillance study. Clinical Infectious Diseases 72, e184–e191.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7665442</ArticleId><ArticleId IdType="pubmed">33150393</ArticleId></ArticleIdList></Reference><Reference><Citation>Middeldorp M, et al. (2021) Short term impact of the COVID-19 pandemic on incidence of vaccine preventable diseases and participation in routine infant vaccinations in the Netherlands in the period March-September 2020. Vaccine 39, 1039–1043.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7787078</ArticleId><ArticleId IdType="pubmed">33478793</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicolay N, et al. (2020) Epidemiology of measles during the COVID-19 pandemic, a description of the surveillance data, 29 EU/EEA countries and the United Kingdom, January to May 2020. Euro Surveillance 25, 2001390.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7459270</ArticleId><ArticleId IdType="pubmed">32762795</ArticleId></ArticleIdList></Reference><Reference><Citation>Love NK, et al. (2022) Impact of the COVID-19 pandemic on gastrointestinal infection trends in England, February-July 2020. BMJ Open 12, e050469.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8968111</ArticleId><ArticleId IdType="pubmed">35314468</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim S, et al. (2022) Trends in gastrointestinal infections before and during non-pharmaceutical interventions in Korea in comparison with the United States. Epidemiology and Health 44, e2022011.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9117109</ArticleId><ArticleId IdType="pubmed">34990526</ArticleId></ArticleIdList></Reference><Reference><Citation>Nachamkin I, et al. (2021) Reduction in sporadic norovirus infections following the start of the COVID-19 pandemic, 2019-2020, Philadelphia. Infectious Diseases and Therapy 10, 1793–1798.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8197782</ArticleId><ArticleId IdType="pubmed">34120315</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie O, et al. (2020) Physical distancing and non-respiratory notifiable diseases in the Northern Territory, March-May 2020. Communicable Diseases Intelligence (2018) 44, 1–6.</Citation><ArticleIdList><ArticleId IdType="pubmed">33278872</ArticleId></ArticleIdList></Reference><Reference><Citation>Havelaar AH, et al. Attribution of foodborne pathogens using structured expert elicitation. Foodborne pathogens and disease. 2008;5:649–59.</Citation><ArticleIdList><ArticleId IdType="pubmed">18687052</ArticleId></ArticleIdList></Reference><Reference><Citation>Ndumbi P, et al. (2018) Hepatitis A outbreak disproportionately affecting men who have sex with men (MSM) in the European Union and European Economic Area, June 2016 to May 2017. Euro Surveillance 23, 1700641.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6205254</ArticleId><ArticleId IdType="pubmed">30131095</ArticleId></ArticleIdList></Reference><Reference><Citation>Mughini-Gras L, et al. (2022) A statistical modelling approach for source attribution meta-analysis of sporadic infection with foodborne pathogens. Zoonoses Public Health 69, 475–486.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9545847</ArticleId><ArticleId IdType="pubmed">35267243</ArticleId></ArticleIdList></Reference><Reference><Citation>Czeisler M, et al. (2020) Delay or avoidance of medical care because of COVID-19-related concerns - United States. MMWR Morbidity and Mortality Weekly Report 69, 1250–1257.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7499838</ArticleId><ArticleId IdType="pubmed">32915166</ArticleId></ArticleIdList></Reference><Reference><Citation>Steffen R, Lautenschlager S and Fehr J (2020) Travel restrictions and lockdown during the COVID-19 pandemic-impact on notified infectious diseases in Switzerland. Journal of Travel Medicine 27, taaa180.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7543597</ArticleId><ArticleId IdType="pubmed">33152761</ArticleId></ArticleIdList></Reference><Reference><Citation>Ray LC, et al. (2021) Decreased incidence of infections caused by pathogens transmitted commonly through food during the COVID-19 pandemic - Foodborne diseases active surveillance network, 10 U.S. Sites, 2017-2020. MMWR Morbidity and Mortality Weekly Report 70, 1332–1336.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8459900</ArticleId><ArticleId IdType="pubmed">34555002</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang LP, et al. (2021) The changing pattern of enteric pathogen infections in China during the COVID-19 pandemic: A nation-wide observational study. The Lancet Regional Health Western Pacific 16, 100268.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8450280</ArticleId><ArticleId IdType="pubmed">34568854</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahn SY, et al. (2021) Changes in the occurrence of gastrointestinal infections after COVID-19 in Korea. Journal of Korean Medical Science 36, e180.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8216988</ArticleId><ArticleId IdType="pubmed">34155841</ArticleId></ArticleIdList></Reference><Reference><Citation>Love NK, et al. (2023) Understanding the impact of the COVID-19 pandemic response on GI infection surveillance trends in England, January 2020-April 2022. Epidemiology &amp; Infection 151, e147.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10540168</ArticleId><ArticleId IdType="pubmed">37622322</ArticleId></ArticleIdList></Reference><Reference><Citation>Bassal R, Keinan-Boker L and Cohen D (2021) A significant decrease in the incidence of Shigellosis in Israel during COVID-19 pandemic. International Journal of Environmental Research and Public Health 18, 3070.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8002282</ArticleId><ArticleId IdType="pubmed">33809746</ArticleId></ArticleIdList></Reference><Reference><Citation>Mughini-Gras L, et al. (2021) Impact of the COVID-19 pandemic on human salmonellosis in the Netherlands. Epidemiology &amp; Infection 149, e254.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8692841</ArticleId><ArticleId IdType="pubmed">36318161</ArticleId></ArticleIdList></Reference><Reference><Citation>Nielsen RT, et al. (2022) COVID-19 preventive measures coincided with a marked decline in other infectious diseases in Denmark, spring 2020. Epidemiology &amp; Infection 150, e138.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9343452</ArticleId><ArticleId IdType="pubmed">35899864</ArticleId></ArticleIdList></Reference><Reference><Citation>de Miguel Buckley R, et al. (2020) Social distancing to combat COVID-19 led to a marked decrease in food-borne infections and sexually transmitted diseases in Spain. Journal of Travel Medicine 27, taaa134.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7499626</ArticleId><ArticleId IdType="pubmed">32841356</ArticleId></ArticleIdList></Reference><Reference><Citation>Collins JP, et al. (2022) Preliminary incidence and trends of infections caused by pathogens transmitted commonly through food - Foodborne diseases active surveillance network, 10 U.S. Sites, 2016-2021. MMWR Morbidity and Mortality Weekly Report 71, 1260–1264.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9541031</ArticleId><ArticleId IdType="pubmed">36201372</ArticleId></ArticleIdList></Reference><Reference><Citation>den Hartog G, et al. (2023) Decline of RSV-specific antibodies during the COVID-19 pandemic. The Lancet Infectious Diseases 23,23–25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9714975</ArticleId><ArticleId IdType="pubmed">36463892</ArticleId></ArticleIdList></Reference><Reference><Citation>Friesema I, et al. Annual report 2021 on enteric infections and zoonoses. Bilthoven; 2022.</Citation></Reference><Reference><Citation>Corona Gedragsunit (2021) Samenvatting onderzoeksresultaten Gedragsregels en Welbevinden: RIVM. Available at https://www.rivm.nl/gedragsonderzoek/maatregelen-welbevinden/samenvatting-onderzoeksresultaten.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle>